Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): A Patient Guide

Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH), also known as Bilateral Macronodular Adrenal Disease (BMAD), is a rare condition where both adrenal glands develop multiple large nodules, or “macronodules.” These nodules are usually benign once the diagnosis is established, but they can be problematic because they produce cortisol—the body’s primary stress hormone—without following the natural signals from the brain. In a healthy system, the pituitary gland act as a thermostat to regulate cortisol; in PBMAH, the adrenal glands become “autonomous,” essentially ignoring the thermostat and pumping out hormone on their own ^[1][2].

The impact of this excess cortisol varies widely from person to person. Some individuals have “overt” Cushing syndrome, which causes visible physical changes such as weight gain, muscle weakness, and skin changes. However, many people are diagnosed with Mild Autonomous Cortisol Secretion (MACS), where the extra hormone isn’t causing obvious outward signs but is quietly contributing to high blood pressure, type 2 diabetes, or thinning bones over many years ^[3][4]. Because these symptoms are common in the general population, PBMAH is often discovered incidentally during a scan for an unrelated medical issue ^[5].

What This Diagnosis Does and Does Not Mean

Finding bilateral adrenal nodules does not mean they are automatically cancerous, nor does it guarantee you have overt Cushing syndrome. PBMAH is generally benign, but requires specialist imaging characterization and individualized follow-up.

Underlying this condition is a complex biological and genetic foundation. In some cases, scientists have identified specific genetic mutations, most notably in the ARMC5 gene, which can cause the adrenal glands to grow these nodules and produce excess hormone. If a confirmed pathogenic germline mutation is found, it can provide a roadmap for the patient’s family, allowing siblings or children to seek genetic counseling and targeted screening ^[6][7]. Not every case is inherited, and surveillance plans are highly individualized.

Managing PBMAH is a long-term commitment that focuses on restoring the body’s hormonal balance. Treatment is highly personalized and may include medications to block cortisol production or surgery to remove one or both adrenal glands. The choice of treatment depends on the severity of the hormone excess and the patient’s overall health goals. While surgery can offer a definitive cure or significant improvement, all patients require ongoing monitoring to track their cardiometabolic health and ensure their cortisol levels remain in a safe range ^[1][8]. With expert care and consistent follow-up, individuals with PBMAH can effectively manage their symptoms and protect their long-term well-being.